Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Observation
|
Mid-range Performer
351.8500
2.45
(
0.70
%)
NSE
Oct 14, 2025
15:31 PM
Volume:
4.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
16 Aug 2023
US FDA Observation
351.85
0.70%
BIOCON LTD
Hold:
Biocon Ltd.
by
Geojit BNP Paribas
Target: 273
Target
Geojit BNP Paribas
Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.
More from Biocon Ltd.
Recommended
Market closes lower, ICICI Prudential's Q2 revenue falls 52% YoY
Trendlyne Marketwatch |
14 Oct 2025, 04:05PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
|
13 Oct 2025, 04:01PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020